-transparent.png){kind=logo}
1 Effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) were measured in two groups of 12 patients both at rest and during sub-maximal cycloergometer exercise while on placebo and after 3 months of treatment with either labetalol or propranolol. 2 ERPF increased and renal vascular resistance decreased both at rest and during exercise after labetalol treatment, compared with placebo; the opposite was observed after propranolol treatment. 3 GFR increased after labetalol and decreased after propranolol both at rest and during exercise, compared with placebo, but these changes were not statistically significant. 4 Labetalol and propranolol resulted in the same decrease in blood pressure and a comparable incidence of side effects.
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
May 1986,
Scandinavian journal of clinical and laboratory investigation,
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
November 1973,
Bruxelles medical,
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
January 1987,
Journal of cardiovascular pharmacology,
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
January 1980,
Postgraduate medical journal,
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
August 1980,
European journal of clinical pharmacology,
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
April 1987,
Liver,
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
January 1985,
International angiology : a journal of the International Union of Angiology,
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
January 1980,
Postgraduate medical journal,
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
September 1987,
Journal of clinical hypertension,
P L Malini, and
E Strocchi, and
S Negroni, and
E Ambrosioni, and
B Magnani
January 1983,
Kardiologia polska,
